Prostate cancer and prostatic diseases Best of China, 2018
Prostate cancer and prostatic diseases Best of China, 2018, Published online: 05 December 2018; doi:10.1038/s41391-018-0117-yProstate cancer and prostatic diseases Best of China, 2018 (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 5, 2018 Category: Urology & Nephrology Authors: Ding-Wei Ye Yao Zhu Source Type: research

Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery
Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery, Published online: 30 November 2018; doi:10.1038/s41391-018-0116-zPreoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 30, 2018 Category: Urology & Nephrology Authors: Fredrik J äderling Olof Akre Markus Aly Johan Bj örklund Mats Olsson Christofer Adding Michael Öberg Lennart Blomqvist Tommy Nyberg Peter Wiklund Stefan Carlsson Source Type: research

Relationship between nocturia and mortality: are we missing the forest for the trees?
Relationship between nocturia and mortality: are we missing the forest for the trees?, Published online: 28 November 2018; doi:10.1038/s41391-018-0115-0Relationship between nocturia and mortality: are we missing the forest for the trees? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 28, 2018 Category: Urology & Nephrology Authors: Vincent Misra ï Benoit Peyronnet Helene Charbonneau David Attias Atul Pathak Source Type: research

Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer
Effect of early salvage radiotherapy at PSA 
Source: Prostate Cancer and Prostatic Diseases - November 28, 2018 Category: Urology & Nephrology Authors: Dirk Bottke Detlef Bartkowiak Alessandra Siegmann Reinhard Thamm Dirk B öhmer Volker Budach Thomas Wiegel Source Type: research

Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis
Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis, Published online: 28 November 2018; doi:10.1038/s41391-018-0113-2Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 28, 2018 Category: Urology & Nephrology Authors: Francesco Cantiello Giorgio Ivan Russo Sascha Kaufmann Giovanni Cacciamani Fabio Crocerossa Matteo Ferro Ottavio De Cobelli Walter Artibani Sebastiano Cimino Giuseppe Morgia Rocco Damiano Konstantin Nikolaou Nils Kr öger Arnulf Stenzl Jens Bedke Stephan Source Type: research

The role of Prostate Imaging Reporting and Data System score in Gleason 3 + 3 active surveillance candidates enrollment: a diagnostic meta-analysis
The role of Prostate Imaging Reporting and Data System score in Gleason 3 + 3 active surveillance candidates enrollment: a diagnostic meta-analysisThe role of Prostate Imaging Reporting and Data System score in Gleason 3 + 3 active surveillance candidates enrollment: a diagnostic meta-analysis, Published online: 14 November 2018; doi:10.1038/s41391-018-0111-4The role of Prostate Imaging Reporting and Data System score in Gleason 3 + 3 active surveillance candidates enrollment: a diagnostic meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 14, 2018 Category: Urology & Nephrology Authors: Lingyun Zhai Yu Fan Yisen Meng Xueru Feng Wei Yu Jie Jin Source Type: research

Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors
Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors, Published online: 14 November 2018; doi:10.1038/s41391-018-0109-yImmediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 14, 2018 Category: Urology & Nephrology Authors: Hanneke Jansen Inge M. van Oort George van Andel Bart P. Wijsman Floris J. Pos Maarten C. C. M. Hulshof Christina A. Hulsbergen-van de Kaa Geert J. L. H. van Leenders Jurgen.J. F ütterer Diederink M. Somford Martijn B. Busstra Reindert J. A. van Moorsela Source Type: research

Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer
Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer, Published online: 09 November 2018; doi:10.1038/s41391-018-0107-0Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 9, 2018 Category: Urology & Nephrology Authors: Rachael L. Sherrer Zachary A. Glaser Jennifer B. Gordetsky Jeffrey W. Nix Kristin K. Porter Soroush Rais-Bahrami Source Type: research

Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test, Published online: 09 November 2018; doi:10.1038/s41391-018-0098-xCirculating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 9, 2018 Category: Urology & Nephrology Authors: Enrique Gonz ález-Billalabeitia Vincenza Conteduca Daniel Wetterskog Anuradha Jayaram Gerhardt Attard Source Type: research

Quantification of bone flare on 18F-NaF PET/CT in metastatic castration-resistant prostate cancer
Quantification of bone flare on 18F-NaF PET/CT in metastatic castration-resistant prostate cancer, Published online: 09 November 2018; doi:10.1038/s41391-018-0110-5Quantification of bone flare on 18F-NaF PET/CT in metastatic castration-resistant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 9, 2018 Category: Urology & Nephrology Authors: Amy J. Weisman Stephanie A. Harmon Timothy G. Perk Jens Eickhoff Peter L. Choyke Karen A. Kurdziel William L. Dahut John L. Humm Andrea B. Apolo Steven M. Larson Michael J. Morris Scott B. Perlman Glenn Liu Robert Jeraj Source Type: research

Impact of lower urinary tract symptoms on mortality: a 21-year follow-up among middle-aged and elderly Finnish men
Impact of lower urinary tract symptoms on mortality: a 21-year follow-up among middle-aged and elderly Finnish men, Published online: 08 November 2018; doi:10.1038/s41391-018-0108-zImpact of lower urinary tract symptoms on mortality: a 21-year follow-up among middle-aged and elderly Finnish men (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 8, 2018 Category: Urology & Nephrology Authors: Jonne Åkerla Jori S Pesonen Antti P öyhönen Jukka H äkkinen Juha Koskim äki Heini Huhtala Teuvo L. J. Tammela Anssi Auvinen Source Type: research

Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study
Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study, Published online: 01 November 2018; doi:10.1038/s41391-018-0105-2Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 1, 2018 Category: Urology & Nephrology Authors: Michael A. Liss Osamah Al-Bayati Jonathan Gelfond Martin Goros Sarah Ullevig John DiGiovanni Jill Hamilton-Reeves Denise O ’Keefe Dean Bacich Brandi Weaver Robin Leach Ian M. Thompson Source Type: research

The impact of surgical duration on complications after transurethral resection of the prostate: an analysis of NSQIP data
The impact of surgical duration on complications after transurethral resection of the prostate: an analysis of NSQIP data, Published online: 01 November 2018; doi:10.1038/s41391-018-0104-3The impact of surgical duration on complications after transurethral resection of the prostate: an analysis of NSQIP data (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 1, 2018 Category: Urology & Nephrology Authors: Christopher B. Riedinger Richard J. Fantus Richard S. Matulewicz Ryan P. Werntz Joseph F. Rodriguez Norm D. Smith Source Type: research

Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series
Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series, Published online: 01 November 2018; doi:10.1038/s41391-018-0106-1Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 1, 2018 Category: Urology & Nephrology Authors: James L. Mohler Susan Halabi Stephen T. Ryan Ali Al-Daghmin Mitchell H. Sokoloff Gary D. Steinberg Ben L. Sanford James A. Eastham Philip J. Walther Michael J. Morris Eric J. Small Source Type: research

Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer
Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer, Published online: 26 October 2018; doi:10.1038/s41391-018-0103-4Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 26, 2018 Category: Urology & Nephrology Authors: Anders E. Berglund Robert J. Rounbehler Travis Gerke Shivanshu Awasthi Chia-Ho Cheng Mandeep Takhar Elai Davicioni Mohammed Alshalalfa Nicholas Erho Eric A. Klein Stephen J. Freedland Ashley E. Ross Edward M. Schaeffer Bruce J. Trock Robert B. Den John L. Source Type: research

Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality
Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality, Published online: 19 October 2018; doi:10.1038/s41391-018-0102-5Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 19, 2018 Category: Urology & Nephrology Authors: Renata Zelic Valentina Fiano Ericka M. Ebot Sarah Coseo Markt Chiara Grasso Morena Trevisan Laura De Marco Luisa Delsedime Daniela Zugna Lorelei A. Mucci Lorenzo Richiardi Source Type: research

Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer
Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer, Published online: 18 October 2018; doi:10.1038/s41391-018-0091-4Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 18, 2018 Category: Urology & Nephrology Authors: Jui-Ming Liu Tien-Hsing Chen Heng-Chang Chuang Chun-Te Wu Ren-Jun Hsu Source Type: research

Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer
Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer, Published online: 02 October 2018; doi:10.1038/s41391-018-0095-0Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 2, 2018 Category: Urology & Nephrology Authors: Colette A. Whitney Lauren E. Howard Stephen J. Freedland Amanda M. DeHoedt Christopher L. Amling William J. Aronson Matthew R. Cooperberg Christopher J. Kane Martha K. Terris Timothy J. Daskivich Source Type: research

Updates in advanced prostate cancer 2018
Updates in advanced prostate cancer 2018, Published online: 02 October 2018; doi:10.1038/s41391-018-0100-7Updates in advanced prostate cancer 2018 (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 2, 2018 Category: Urology & Nephrology Authors: Andrew J. Armstrong Source Type: research

Prostate cancer disparities in Hispanics by country of origin: a nationwide population-based analysis
Prostate cancer disparities in Hispanics by country of origin: a nationwide population-based analysis, Published online: 02 October 2018; doi:10.1038/s41391-018-0097-yProstate cancer disparities in Hispanics by country of origin: a nationwide population-based analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 2, 2018 Category: Urology & Nephrology Authors: Ryan W. Dobbs Neha R. Malhotra Michael R. Abern Daniel M. Moreira Source Type: research

Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy
Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy, Published online: 02 October 2018; doi:10.1038/s41391-018-0092-3Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 2, 2018 Category: Urology & Nephrology Authors: Wei Phin Tan Dimitri Papagiannopoulos Kalyan C Latchamsetty Nathaniel Wilson Nicholas O ’Block Lester Raff Alfredo Mena Lora Christopher L Coogan Michael R Abern Source Type: research

Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning
Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning, Published online: 02 October 2018; doi:10.1038/s41391-018-0094-1Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 2, 2018 Category: Urology & Nephrology Authors: Lucy A. M. Simmons Abi Kanthabalan Manit Arya Tim Briggs Susan C. Charman Alex Freeman James Gelister Charles Jameson Neil McCartan Caroline M. Moore Jan van der Muelen Mark Emberton Hashim U. Ahmed Source Type: research

Impact of age on exposure to oral antiandrogen therapies in clinical practice
Impact of age on exposure to oral antiandrogen therapies in clinical practice, Published online: 02 October 2018; doi:10.1038/s41391-018-0096-zImpact of age on exposure to oral antiandrogen therapies in clinical practice (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 2, 2018 Category: Urology & Nephrology Authors: Marie-Rose B. S. Crombag Merel van Nuland Andries M. Bergman Hilde Rosing Jan H. M. Schellens Alwin D. R. Huitema Jos H. Beijnen Source Type: research

Nutrition care guidelines for men with prostate cancer undergoing androgen deprivation therapy: do we have enough evidence?
Nutrition care guidelines for men with prostate cancer undergoing androgen deprivation therapy: do we have enough evidence?, Published online: 02 October 2018; doi:10.1038/s41391-018-0099-9Nutrition care guidelines for men with prostate cancer undergoing androgen deprivation therapy: do we have enough evidence? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 2, 2018 Category: Urology & Nephrology Authors: Katelyn A. Barnes Lauren E. Ball Daniel A. Galv ão Robert U. Newton Suzanne K. Chambers Source Type: research

PTEN status assessment in the Johns Hopkins active surveillance cohort
PTEN status assessment in the Johns Hopkins active surveillance cohort, Published online: 02 October 2018; doi:10.1038/s41391-018-0093-2PTEN status assessment in the Johns Hopkins active surveillance cohort (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 2, 2018 Category: Urology & Nephrology Authors: Jeffrey J. Tosoian Liana B. Guedes Carlos L. Morais Mufaddal Mamawala Ashley E. Ross Angelo M. De Marzo Bruce J. Trock Misop Han H. Ballentine Carter Tamara L. Lotan Source Type: research

Nocturia and associated mortality: observational data from the REDUCE trial
Nocturia and associated mortality: observational data from the REDUCE trial, Published online: 13 September 2018; doi:10.1038/s41391-018-0090-5Nocturia and associated mortality: observational data from the REDUCE trial (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 13, 2018 Category: Urology & Nephrology Authors: Donald L. Bliwise Lauren E. Howard Daniel M. Moreira Gerald L. Andriole Martin L. Hopp Stephen J. Freedland Source Type: research

Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data
Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data, Published online: 13 September 2018; doi:10.1038/s41391-018-0088-zImportance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 13, 2018 Category: Urology & Nephrology Authors: Chang Wook Jeong Minyong Kang Seung Il Jung Tae-Hwan Kim Sung Woo Park Jae Young Joung Seong Soo Jeon Jun Hyuk Hong Ji Youl Lee Byung Ha Chung Hanjong Ahn Choung-Soo Kim Dong Deuk Kwon Cheol Kwak Source Type: research

Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer
Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer, Published online: 13 September 2018; doi:10.1038/s41391-018-0087-0Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 13, 2018 Category: Urology & Nephrology Authors: Teemu J. Murtola Tatu V. J. Kasurinen Kirsi Talala Kimmo Taari Teuvo L. J. Tammela Anssi Auvinen Source Type: research

Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer
Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer, Published online: 05 September 2018; doi:10.1038/s41391-018-0089-yImpact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 5, 2018 Category: Urology & Nephrology Authors: Subhayan Chattopadhyay Otto Hemminki Asta F örsti Kristina Sundquist Jan Sundquist Kari Hemminki Source Type: research

Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer
Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer, Published online: 31 August 2018; doi:10.1038/s41391-018-0083-4Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 31, 2018 Category: Urology & Nephrology Authors: Marieke J. Krimphove Alexander P. Cole Sean A. Fletcher Sabrina S. Harmouch Sebastian Berg Stuart R. Lipsitz Maxine Sun Junaid Nabi Paul L. Nguyen Jim C. Hu Adam S. Kibel Toni K. Choueiri Luis A. Kluth Quoc-Dien Trinh Source Type: research

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort
The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort, Published online: 31 August 2018; doi:10.1038/s41391-018-0082-5The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 31, 2018 Category: Urology & Nephrology Authors: Axel M öller Henrik Olsson Henrik Gr önberg Martin Eklund Markus Aly Tobias Nordstr öm Source Type: research

Practice patterns of primary EBRT with and without ADT in prostate cancer treatment
Practice patterns of primary EBRT with and without ADT in prostate cancer treatment, Published online: 31 August 2018; doi:10.1038/s41391-018-0084-3Practice patterns of primary EBRT with and without ADT in prostate cancer treatment (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 31, 2018 Category: Urology & Nephrology Authors: Bogdana Schmidt Renu S. Eapen Janet E. Cowan Jeanette M. Broering Kirsten L. Greene Peter R. Carroll Matthew R. Cooperberg Source Type: research

Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage
Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage, Published online: 31 August 2018; doi:10.1038/s41391-018-0086-1Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 31, 2018 Category: Urology & Nephrology Authors: Catherine Handy Marshall Wei Fu Hao Wang Alexander S. Baras Tamara L. Lotan Emmanuel S. Antonarakis Source Type: research

Estrogens and prostate cancer
Estrogens and prostate cancer, Published online: 21 August 2018; doi:10.1038/s41391-018-0081-6Estrogens and prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 21, 2018 Category: Urology & Nephrology Authors: Ryan W. Dobbs Neha R. Malhotra David T. Greenwald Alice Y. Wang Gail S. Prins Michael R. Abern Source Type: research

Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations, Published online: 21 August 2018; doi:10.1038/s41391-018-0079-0Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 21, 2018 Category: Urology & Nephrology Authors: E. David Crawford Axel Heidenreich Nathan Lawrentschuk Bertrand Tombal Antonio C. L. Pompeo Arturo Mendoza-Valdes Kurt Miller Frans M. J. Debruyne Laurence Klotz Source Type: research

Bipolar plasma enucleation of the prostate vs. open prostatectomy in large benign prostatic hyperplasia: a single centre 3-year comparison
Bipolar plasma enucleation of the prostate vs. open prostatectomy in large benign prostatic hyperplasia: a single centre 3-year comparison, Published online: 21 August 2018; doi:10.1038/s41391-018-0080-7Bipolar plasma enucleation of the prostate vs. open prostatectomy in large benign prostatic hyperplasia: a single centre 3-year comparison (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 21, 2018 Category: Urology & Nephrology Authors: Roberto Giulianelli Barbara Cristina Gentile Gabriella Mirabile Giorgia Tema Luca Albanesi Paola Tariciotti Giorgio Rizzo Cristina Falavolti Pietro Aloisi Giorgio Vincenti Riccardo Lombardo Source Type: research

BRCAness and prostate cancer: diagnostic and therapeutic considerations
BRCAness and prostate cancer: diagnostic and therapeutic considerations, Published online: 21 August 2018; doi:10.1038/s41391-018-0069-2BRCAness and prostate cancer: diagnostic and therapeutic considerations (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 21, 2018 Category: Urology & Nephrology Authors: Mallika Dhawan Charles J. Ryan Source Type: research

Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study
Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study, Published online: 20 August 2018; doi:10.1038/s41391-018-0076-3Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 20, 2018 Category: Urology & Nephrology Authors: Tim M. Govers Daphne Hessels Virginie Vlaeminck-Guillem Bernd J. Schmitz-Dr äger Christian G. Stief Claudio Martinez-Ballesteros Matteo Ferro Angel Borque-Fernando Jose Rubio-Briones J. P. Michiel Sedelaar Wim van Criekinge Jack A. Schalken Source Type: research

Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapies
Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapies, Published online: 16 August 2018; doi:10.1038/s41391-018-0078-1Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapies (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 16, 2018 Category: Urology & Nephrology Authors: Sigfred Ian R. Alpajaro Jerad A. K. Harris Christopher P. Evans Source Type: research

MRI in active surveillance: a critical review
MRI in active surveillance: a critical review, Published online: 16 August 2018; doi:10.1038/s41391-018-0077-2MRI in active surveillance: a critical review (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 16, 2018 Category: Urology & Nephrology Authors: Vasilis Stavrinides Francesco Giganti Mark Emberton Caroline M. Moore Source Type: research

Incidence and risk factors of suicide after a prostate cancer diagnosis: a meta-analysis of observational studies
Incidence and risk factors of suicide after a prostate cancer diagnosis: a meta-analysis of observational studies, Published online: 14 August 2018; doi:10.1038/s41391-018-0073-6Incidence and risk factors of suicide after a prostate cancer diagnosis: a meta-analysis of observational studies (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 14, 2018 Category: Urology & Nephrology Authors: Zhenlang Guo Shu Gan Yuan Li Chiming Gu Songtao Xiang Jianfu Zhou Leiliang Gong Franky Leung Chan Shusheng Wang Source Type: research

Prostate cancer risk factors in black and white men in the NIH-AARP Diet and Health Study
Prostate cancer risk factors in black and white men in the NIH-AARP Diet and Health Study, Published online: 14 August 2018; doi:10.1038/s41391-018-0070-9Prostate cancer risk factors in black and white men in the NIH-AARP Diet and Health Study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 14, 2018 Category: Urology & Nephrology Authors: Tracy M. Layne Barry I. Graubard Xiaomei Ma Susan T. Mayne Demetrius Albanes Source Type: research

Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysis
Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysis, Published online: 14 August 2018; doi:10.1038/s41391-018-0075-4Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 14, 2018 Category: Urology & Nephrology Authors: Niranjan J. Sathianathen Mohit Butaney Connie Bongiorno Badrinath R. Konety Damien M. Bolton Nathan Lawrentschuk Source Type: research

Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance
Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance, Published online: 14 August 2018; doi:10.1038/s41391-018-0074-5Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 14, 2018 Category: Urology & Nephrology Authors: Ángel Borque-Fernando Jos é Rubio-Briones Luis M. Esteban Yan Dong Ana Calatrava Álvaro Gómez-Ferrer Enrique G ómez-Gómez Jes ús M. Gil Fabra Nuria Rodr íguez-García Pedro Á. López González Jorge Garc ía-Rodríguez Miguel Rodrigo-Aliaga Berna Source Type: research

MRI in prostate cancer diagnosis: do we need to add standard sampling? A review of the last 5 years
MRI in prostate cancer diagnosis: do we need to add standard sampling? A review of the last 5 years, Published online: 13 August 2018; doi:10.1038/s41391-018-0071-8MRI in prostate cancer diagnosis: do we need to add standard sampling? A review of the last 5 years (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 13, 2018 Category: Urology & Nephrology Authors: Armando Stabile Francesco Giganti Mark Emberton Caroline M. Moore Source Type: research

Fructose and prostate cancer: toward an integrated view of cancer cell metabolism
Fructose and prostate cancer: toward an integrated view of cancer cell metabolism, Published online: 13 August 2018; doi:10.1038/s41391-018-0072-7Fructose and prostate cancer: toward an integrated view of cancer cell metabolism (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 13, 2018 Category: Urology & Nephrology Authors: Daniela Carre ño N éstor Corro Ver ónica Torres-Estay Loreto P. V éliz Rodrigo Jaimovich Pedro Cisternas Ignacio F. San Francisco Paula C. Sotomayor Marina Tanasova Nibaldo C. Inestrosa Alejandro S. Godoy Source Type: research

Use of high and very high dose radiotherapy after radical prostatectomy for prostate cancer in the United States
Use of high and very high dose radiotherapy after radical prostatectomy for prostate cancer in the United States, Published online: 07 August 2018; doi:10.1038/s41391-018-0066-5Use of high and very high dose radiotherapy after radical prostatectomy for prostate cancer in the United States (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 7, 2018 Category: Urology & Nephrology Authors: P. Alexidis W. Guo J. E. Bekelman N. Vapiwala P. E. Gabriel J. P. Christodouleas Source Type: research

Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test
Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test, Published online: 07 August 2018; doi:10.1038/s41391-018-0067-4Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 7, 2018 Category: Urology & Nephrology Authors: Michael J. Donovan Gerardo Fernandez Richard Scott Faisal M. Khan Jack Zeineh Giovanni Koll Nataliya Gladoun Elizabeth Charytonowicz Ash Tewari Carlos Cordon-Cardo Source Type: research

Reply to Letter to the Editor re: ‘Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting’
Reply to Letter to the Editor re: ‘Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting’Reply to Letter to the Editor re: ‘Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting’, Published online: 06 August 2018; doi:10.1038/s41391-018-0063-8Reply to Letter to the Editor re: ‘Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting’ (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 6, 2018 Category: Urology & Nephrology Authors: Jay White Ronald F. Tutrone Source Type: research

Relative telomere length and prostate cancer mortality
Relative telomere length and prostate cancer mortality, Published online: 06 August 2018; doi:10.1038/s41391-018-0068-3Relative telomere length and prostate cancer mortality (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 6, 2018 Category: Urology & Nephrology Authors: Wilfried Renner Sabine Krenn-Pilko Hans-J ürgen Gruber Markus Herrmann Tanja Langsenlehner Source Type: research